Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy

Use of copolymer 1 and related peptides and polypeptides and T cells treated herewith for neuroprotective glaucoma therapy

US Patent 7407936 · Granted Aug 5, 2008

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating cognitive decline associated with neurological diseases based2025
Diagnosis of autoimmune disease2024
Methods of treatment of HLA-B27 related inflammatory diseases and compositions r2024
Diagnosis of systemic lupus erythematosus using protein, peptide and oligonucleo2024
Methods and compositions for modulating lymphatic vessels in the central nervous2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Reducing systemic regulatory T cell levels or activity for treatment of amyotrop2024
Use of AKT phosphorylation as a biomarker for prognosing neurodegenerative disea2023
Diagnosis of systemic lupus erythematosus using oligonucleotides antigens2023
Modified anti-PD-L1 antibody and methods and uses for treating a neurodegenerati2023
Compositions and methods of enhancing the homing and/or engraftment of hematopoi2023
Reducing systemic regulatory T cell levels or activity for treatment of a retina2023